0
0
0
Increasing Medication Access for Seniors Act of 2024
12/19/2024, 9:06 AM
Summary of Bill HR 8725
Bill 118 hr 8725, also known as the Increasing Medication Access for Seniors Act of 2024, aims to improve access to affordable prescription medications for senior citizens in the United States. The bill was introduced in the House of Representatives in response to concerns about rising drug prices and the financial burden this places on older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
Current Status of Bill HR 8725
Bill HR 8725 is currently in the status of Bill Introduced since June 13, 2024. Bill HR 8725 was introduced during Congress 118 and was introduced to the House on June 13, 2024. Bill HR 8725's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024
Bipartisan Support of Bill HR 8725
Total Number of Sponsors
2Democrat Sponsors
2Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 8725
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 8725
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
Comments
Sponsors and Cosponsors of HR 8725
Latest Bills
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Bill HR 8646May 5, 2026
A resolution designating the week of April 20 through April 24, 2026, as "National Home Visiting Week".
Bill SRES 692May 5, 2026
Tribal Trust Land Homeownership Act of 2025
Bill S 723May 5, 2026
To amend the Fair Labor Standards Act of 1938 to prohibit discrimination in the payment of wages on account of sex, race, or national origin, and for other purposes.
Bill HR 8663May 5, 2026
RECON Act
Bill HR 8478May 5, 2026
SAFE School Act
Bill HR 8506May 5, 2026
Rehabilitation of Historic Schools Act of 2026
Bill HR 8501May 5, 2026
Precision Agriculture Workforce Training and Development Act
Bill HR 8507May 5, 2026
Public Safety UAS Readiness Act
Bill HR 8492May 5, 2026
Save SNAP Act of 2026
Bill HR 8503May 5, 2026


